SCPH Files Form 25 to Withdraw Nasdaq Listing

Rhea-AI Filing Summary

scPharmaceuticals Inc. submitted a Form 25 notification indicating the company's class of securities will be removed from listing and/or registration on the Nasdaq Stock Market LLC. The form identifies Nasdaq as the exchange and cites the applicable withdrawal/delisting rule provisions. The filing indicates the Exchange and/or Issuer has followed the procedural rules governing a voluntary withdrawal under the Exchange Act.

Positive

• Procedural compliance indicated with applicable Exchange Act rule citations
• Notification filed formally via Form 25, initiating orderly removal process

Negative

• Delisting from Nasdaq which may reduce liquidity for the listed class
• Change in registration status could affect regulatory reporting and investor access

Insights

Exchange Listing Specialist

TL;DR: Form 25 signals the removal of scPharmaceuticals' Nasdaq listing under the exchange's withdrawal/delisting rules.

The filing documents a procedural notification that the issuer's securities will be struck from Nasdaq and references the Exchange Act withdrawal/delisting provisions. It shows Nasdaq and/or the issuer complied with the cited rule sections for removal.

This change alters the trading venue and regulatory status of the listed class of securities; shareholders should note the delisting process timeline and any follow-up notices that explain next steps for trading or registration.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-38293

Issuer:	scPharmaceuticals Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	2400 District Avenue, Suite 310
	Burlington	MASSACHUSETTS	01830
Telephone number:					(781)301-7216

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-10-07	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 25 filed for scPharmaceuticals (SCPH) mean?

Form 25 notifies that the issuer's class of securities will be removed from listing and/or registration on the Nasdaq Stock Market LLC under the Exchange Act rules.

Which exchange is involved in the SCPH Form 25 filing?

The filing lists the Nasdaq Stock Market LLC as the exchange where the securities are/was listed.

Did the Form 25 state whether the withdrawal was voluntary or involuntary?

The filing cites compliance with the Exchange Act provisions that govern a voluntary withdrawal and also references the Exchange's rule-based process; no adversarial allegations are stated.

Will shareholders still be able to trade SCPH after Form 25?

Form 25 starts the removal process from Nasdaq; subsequent notices typically explain trading transition, so trading availability may change once the removal is effective.

What rules did the filing reference for the removal?

The filing references sections of the Exchange Act implementing rules for delisting/withdrawal, including rule citations for voluntary withdrawal and exchange compliance.